Funding
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115